Product image · 10 mg
In Stock · Research Use Only
PT-141
10 mg
PT-141, also known as bremelanotide, is a melanocortin receptor agonist that acts on central nervous-system pathways involved in sexual desire. Bremelanotide has been clinically studied and is FDA approved in a specific prescription formulation for acquired, generalized hypoactive sexual desire disorder in certain premenopausal women.
For laboratory and research applications only
$49.99
Current catalog status
In stock
In stock
Product format
10 mgSingle item
Quantity
US SourcedDomestic distributors
Lab VerifiedBatch documentation
In StockCurrent store status
Strength / Size10 mg
CategoryMelanocortin peptide research
FormatLyophilized research peptide
Price$49.99